Medical Management of Endometriosis: GnRH Antagonists

Published: Dec. 14, 2022, 5 a.m.

Host: Lee Shulman MD, FACOG, FACMG
\n\n Guest: Andrea S. Lukes, MD, MHSc, FACOG
\n\n\n \n

Are you currently considering GnRH antagonists as first-line therapy, or are you waiting for patients to fail other endometriosis treatment approaches first? Drs. Andrea Lukes and Lee Shulman discuss how the advent of effective GnRH antagonists is evolving the care of endometriosis. Are you ready to provide patients with the clinical outcomes they seek while balancing the benefits of medical and surgical approaches?